RNA Based Therapeutics Market by Technology (Enabled Technology and Enabling Technology), by Application (Kidney Diseases, Cardiovascular, Metabolic Disorders, Infectious Diseases, Oncology, and Others), and by End-User (Research, Diagnosis, Therapeutics, and Others)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020–2029

  • TBI782480
  • July 24, 2020
  • Global
  • 132 pages
  • SAC Insights
                                          

Abstract

The report covers a forecast and an analysis of the RNA based therapeutics market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the RNA based therapeutics market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the RNA based therapeutics market on a global and regional level. In order to give the users of this report a comprehensive view of the RNA based therapeutics market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness. The report provides company market share analysis to give a broader overview of the key players in the RNA based therapeutics market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the RNA based therapeutics market on a global and regional basis. The study provides a decisive view of the RNA based therapeutics market by segmenting it based on technology, application, end-user, and region. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further classification into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil. Some key players in RNA based therapeutics market include Quark Pharmaceuticals, Alnylam Pharmaceuticals, Dicerna Pharmaceuticals, Tekmira Pharmaceuticals, Benitec Biopharma, Genzyme Corporation, Ionis Pharmaceuticals, Silence Therapeutics, Cenix BioScience, and Sirnaomics. This report segments the global RNA based therapeutics market into: Global RNA Based Therapeutics Market: By Technology Enabling Technology Microarrays Labeling Purification Linear Amplification qRT-PCR Inhibition Enabled Technology RNA Interference (RNAi) Technologies Small Interfering RNA (siRNA) MicroRNA (miRNA) RNA Antisense Technologies Global RNA Based Therapeutics Market: By Application Cardiovascular Kidney Diseases Oncology Infectious Diseases Metabolic Disorders Others Global RNA Based Therapeutics Market: By End-User Research Therapeutics Diagnosis Others Global RNA Based Therapeutics Market: By Region North America The U.S. Europe UK France Germany Asia Pacific China Japan India Latin America Brazil Middle East and Africa

Table of Contents
                    
                    
                         Request Table Of Content
                         Click To Request Sample
                    

	Chapter 1. Introduction
	
		1.1. Report description and scope
		1.2. Research scope
		1.3. Research methodology
		
			1.3.1. Market research process
			1.3.2. Market research methodology
		
		
	
	
	 
	Chapter 2. Executive Summary
	
		2.1. Global RNA Based Therapeutics Market, 2016-2025 (USD Billion)
		2.2. Global RNA Based Therapeutics Market: Snapshot
	
	
	 
	Chapt
|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form